Breast Cancer
Researchers from Italy and the United States report details of new studies and findings in the area of breast cancer
Published in Cancer Weekly, September 12th, 2006
Study 1: Tamoxifen-treated breast cancer may influence the progression of atypical endometrial lesions.
Researchers in Italy report, "The purpose of the present study is to prospectively evaluate the effects of tamoxifen on the pathological behavior of endometrial hyperplasias without atypia, diagnosed before the start of adjuvant endocrine therapy, in menopausal patients suffering from breast cancer."
"Twenty-six patients suffering from estrogen-receptor positive breast cancer and candidate to receive adjuvant tamoxifen, were found to be...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-09-12)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer outcome associated with status of p53 and MDM2 SNP309 - Crohn Colitis
Crohn colitis patients requiring surgery linked to higher risk of dysplasia and adenocarcinoma - End-of-Life Issues
End-of-life cancer patients' spiritual needs measured by Spiritual Needs Inventory - Endometrial Cancer
Endometrioid endometrial carcinoma's loss of PTEN expression linked to cyclin D1 overexpression - Lung Cancer
Lung cancer patients could safely receive higher doses of radiation than traditionally administered - Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia remission is likely when lymphangiogenesis factor is absent - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
